BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11382897)

  • 1. Dorsal raphe nucleus administration of 5-HT1A receptor agonist and antagonists: effect on rapid eye movement sleep in the rat.
    Monti JM; Jantos H; Monti D; Alvariño F
    Sleep Res Online; 2000; 3(1):29-34. PubMed ID: 11382897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat.
    Monti JM; Jantos H; Lagos P
    Behav Brain Res; 2010 Jan; 206(1):8-16. PubMed ID: 19737581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):940-7. PubMed ID: 18295951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OHDPAT: prevention with WAY 100635.
    Monti JM; Jantos H; Monti D
    Eur Neuropsychopharmacol; 2002 Feb; 12(1):47-55. PubMed ID: 11788240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the 5-HT(7) receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2006 Feb; 167(2):245-50. PubMed ID: 16290281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Leopoldo M; Jantos H
    Behav Brain Res; 2008 Aug; 191(2):184-9. PubMed ID: 18466985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.
    Corradetti R; Laaris N; Hanoun N; Laporte AM; Le Poul E; Hamon M; Lanfumey L
    Br J Pharmacol; 1998 Feb; 123(3):449-62. PubMed ID: 9504386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin control of sleep-wake behavior.
    Monti JM
    Sleep Med Rev; 2011 Aug; 15(4):269-81. PubMed ID: 21459634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
    Monti JM; Jantos H; Catenaccio V; Xavier S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1341-8. PubMed ID: 21514352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine.
    Hertel P; Nomikos GG; Svensson TH
    Br J Pharmacol; 1997 Dec; 122(8):1639-46. PubMed ID: 9422809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of dorsal raphe nucleus serotonin 5-HT1A receptor in the regulation of REM sleep.
    Monti JM; Monti D
    Life Sci; 2000 Apr; 66(21):1999-2012. PubMed ID: 10823340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep.
    Monti JM
    Sleep Med Rev; 2010 Oct; 14(5):319-27. PubMed ID: 20153670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo.
    Clifford EM; Gartside SE; Umbers V; Cowen PJ; Hajós M; Sharp T
    Br J Pharmacol; 1998 May; 124(1):206-12. PubMed ID: 9630361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of the 5-HT1A receptor agonist flesinoxan given locally or systemically on REM sleep in the rat.
    Monti JM; Jantos H
    Eur J Pharmacol; 2003 Oct; 478(2-3):121-30. PubMed ID: 14575796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of dorsal raphe neurons in paradoxical sleep generation in the cat: no evidence for a serotonergic mechanism.
    Sakai K; Crochet S
    Eur J Neurosci; 2001 Jan; 13(1):103-12. PubMed ID: 11135008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP mediates circadian phase shifts induced by microinjection of serotonergic drugs in the hamster dorsal raphe nucleus.
    Duncan MJ; Davis VA
    Brain Res; 2005 Oct; 1058(1-2):10-6. PubMed ID: 16150426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: site-dependent effects on REM sleep.
    Monti JM; Leopoldo M; Jantos H; Lagos P
    Pharmacol Biochem Behav; 2012 Aug; 102(2):373-80. PubMed ID: 22659581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleep and waking following microdialysis perfusion of the selective 5-HT1A receptor antagonist p-MPPI into the dorsal raphe nucleus in the freely moving rat.
    Sørensen E; Grønli J; Bjorvatn B; Bjørkum A; Ursin R
    Brain Res; 2001 Apr; 897(1-2):122-30. PubMed ID: 11282365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.